share_log

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

周三盘后交易时段，12只医疗保健类股走势
Benzinga ·  2023/09/14 05:31

Gainers

获胜者

  • Infinity Pharmaceuticals (NASDAQ:INFI) shares increased by 23.7% to $0.04 during Wednesday's after-market session. Trading volume for this security closed at 3.2 million, accounting for 94.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.9 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) shares moved upwards by 15.55% to $1.04. The company's market cap stands at $2.1 million.
  • Longeveron Inc. - Subscription Right (NASDAQ:LGVNR) shares increased by 14.94% to $0.01.
  • Scinai Immunotherapeutics (NASDAQ:SCNI) shares increased by 11.45% to $1.46. Today's trading volume for this security ended up closing at 582.8K shares, which is 6319.1 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $5.3 million.
  • Avalo Therapeutics (NASDAQ:AVTX) stock rose 10.86% to $0.25. Trading volume for this security closed at 94.4 million, accounting for 886.9% of its average full-day volume over the last 100 days. The company's market cap stands at $5.0 million.
  • NanoString Technologies (NASDAQ:NSTG) stock rose 10.55% to $1.99. The company's market cap stands at $94.6 million.
  • 无限制药 纳斯达克股票代码：INFI）股价在周三的盘后交易时段上涨23.7％，至0.04美元。该证券的交易量收于320万只，占其过去100天平均全天交易量的94.2％。他们流通股的市值为390万美元。
  • TransCode 治疗学 纳斯达克股票代码：RNAZ）股价上涨15.55％，至1.04美元。该公司的市值为210万美元。
  • Longeveron Inc.-订阅权 纳斯达克股票代码：LGVNR）股价上涨14.94％，至0.01美元。
  • Scinai Immunotherapeutics 纳斯达克股票代码：SCNI）股价上涨11.45％，至1.46美元。该证券今天的交易量最终收于58.28万股，占其过去100天平均交易量的63.19.1％。他们流通股的市值为530万美元。
  • Avalo 疗法 纳斯达克股票代码：AVTX）股价上涨10.86％，至0.25美元。该证券的交易量收于9,440万股，占其过去100天平均全天交易量的886.9％。该公司的市值为500万美元。
  • NanoString 纳斯达克股票代码：NSTG）股价上涨10.55％，至1.99美元。该公司的市值为9,460万美元。

Losers

失败者

  • Kiromic BioPharma (NASDAQ:KRBP) shares declined by 51.0% to $0.71 during Wednesday's after-market session. At the close, Kiromic BioPharma's trading volume reached 65.0K shares. This is 90.6% of its average volume over the last 100 days.
  • OKYO Pharma (NASDAQ:OKYO) stock decreased by 25.26% to $1.48. At the close, OKYO Pharma's trading volume reached 62.9K shares. This is 26.7% of its average volume over the last 100 days. The company's market cap stands at $37.8 million.
  • Bionomics (NASDAQ:BNOX) stock declined by 22.35% to $1.39. Today's trading volume for this security ended up closing at 226.7K shares, which is 112.6 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $11.3 million.
  • Impel Pharmaceuticals (NASDAQ:IMPL) shares decreased by 12.05% to $0.73. At the close, Impel Pharmaceuticals's trading volume reached 281.1K shares. This is 31.6% of its average volume over the last 100 days. The company's market cap stands at $17.3 million.
  • Creative Medical Tech (NASDAQ:CELZ) stock fell 8.16% to $5.18. This security traded at a volume of 343.5K shares come close, making up 450.3% of its average volume over the last 100 days. The company's market cap stands at $7.4 million.
  • Joint (NASDAQ:JYNT) stock decreased by 7.49% to $8.65. The market value of their outstanding shares is at $126.9 million. The company's, Q2 earnings came out today. See Also:
  • Kiromic BioPharm 纳斯达克股票代码：KRBP）股价在周三的盘后交易时段下跌51.0％，至0.71美元。收盘时，Kiromic BioPharma的交易量达到6.5万股。这是其过去100天平均交易量的90.6％。
  • 东京制药 纳斯达克股票代码：OKYO）股价下跌25.26％，至1.48美元。收盘时，OKYO制药的交易量达到6.29万股。这是其过去100天平均交易量的26.7％。该公司的市值为3,780万美元。
  • 生物学 纳斯达克股票代码：BNOX）股价下跌22.35％，至1.39美元。该证券今天的交易量最终收于22.67万股，占其过去100天平均交易量的112.6％。他们流通股的市值为1,130万美元。
  • Impel 制药 纳斯达克股票代码：IMPL）股价下跌12.05％，至0.73美元。收盘时，Impel Pharmicals的交易量达到28.11万股。这是其过去100天平均交易量的31.6％。该公司的市值为1,730万美元。
  • 创新医疗科技 纳斯达克股票代码：CELZ）股价下跌8.16％，至5.18美元。该证券的交易量为343.5万股，占其过去100天平均交易量的450.3％。该公司的市值为740万美元。
  • 联合 纳斯达克股票代码：JYNT）股价下跌7.49％，至8.65美元。他们流通股的市值为1.269亿美元。该公司第二季度财报今天公布。 另请参阅：

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成，并由编辑审阅。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发